Study of TTI-101 in Participants With Idiopathic Pulmonary Fibrosis

NCT05671835 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

100

Enrollment

INDUSTRY

Sponsor class

Conditions

Idiopathic Pulmonary Fibrosis

Interventions

DRUG: TTI-101
DRUG: Placebo

Sponsor

Tvardi Therapeutics, Incorporated